Dry Powder Epinephrine Nasal Spray – Fast, Pain-Free Relief Coming Soon
Nasdepi® by Belhaven Biopharma is designed for rapid response when every second counts. No needles. No fear. Just life-saving power in your pocket.
Our patented technology delivers life-saving medication through Nasdepi®, the first-ever dry powder epinephrine nasal spray for treating severe allergic reactions and anaphylaxis. Currently in clinical trials, Nasdepi® is engineered for rapid absorption, needle-free delivery, and simple, intuitive use. It offers a pain-free alternative to traditional epinephrine auto-injectors, in a compact form designed to overcome needle phobia and fit seamlessly into everyday life.
Despite the dire consequences, epinephrine auto-injector devices are only available in 60% of countries, primarily high-income regions. Many countries in South America, Africa, the Middle East, and Asia-Pacific either lack access to these life-saving epinephrine treatments or depend on individual importation.
This lack of accessibility and standardization motivated us to develop Nasdepi®—a dry powder epinephrine nasal spray designed to improve epinephrine absorption, simplify emergency use, and provide a longer shelf life and heat resistance to support access in underserved regions.
In the U.S., less than half of Americans at risk are equipped with injectable epinephrine pens. Shockingly, one-third of those who experience an allergic reaction don’t use epinephrine due to needle phobia, uncertainty about how to use the device, or expired products.
The stakes are incredibly high; a delay in treatment can mean the difference between life and death. Nasdepi® eliminates these barriers with its compact, user-friendly design that fits in your pocket, ensuring immediate access to treatment and setting a new standard for needle-free anaphylaxis care.Every Year over 4 million people experience life-threatening allergic reactions (anaphylaxis) globally.
Outdoor workers and adventurers face unreliable epinephrine auto-injectors in extreme temperatures. Nasdepi®, a dry powder epinephrine nasal spray, is compact, shelf-stable, and needle-free—ready to deliver reliable treatment for allergy emergencies in any environment.
Nasdepi®’s dry powder epinephrine nasal spray remains stable in extreme heat and humidity, making it ideal for regions where injectable epinephrine is unreliable. This needle-free, shelf-stable alternative expands access to life-saving allergy treatment in underserved communities worldwide.
Belhaven Biopharma’s mission is to make lifesaving allergy treatments more accessible, easier to administer, and pain-free for everyone living with severe allergies. Nasdepi®, our needle-free epinephrine nasal spray, is a passive device—designed to work without active participation, even if the recipient is unconscious.
Our goal is to ensure that you’re always prepared to respond swiftly and confidently during an allergy emergency, anytime, anywhere. Discover more about Nasdepi® now.
Belhaven Biopharma’s objective is simple: to improve the lives of those with severe allergies by providing safe, effective, and accessible treatment. We understand the emotional toll of living with life-threatening allergies, and our commitment is to help everyone live with confidence—not fear.
Nasdepi®, our needle-free epinephrine nasal spray, is designed with your needs in mind: compact, temperature-stable, pain-free, and ready for allergy emergencies—whether you’re working under the hot sun or heading out for the day.
At Belhaven Biopharma, we’re also committed to global accessibility and sustainable healthcare innovation. Nasdepi® was developed to be:
Compact. Pain-Free. Ready When You Need It.